Skip to content

Evaluation of a Specialized Therapeutic Care of Patients Presenting an Intolerance Attributed to Electromagnetic Fields

Evaluation of a Specialized Therapeutic Care of Patients Presenting an Idiopathic Environmental Intolerance Attributed to Electromagnetic Fields

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01854801
Acronym
IEI-CEM
Enrollment
79
Registered
2013-05-16
Start date
2012-03-09
Completion date
2016-04-30
Last updated
2025-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Environmental Intolerance Attributed to Electromagnetic Fields

Keywords

IEI-EMF, WI-FI, DECT, Electro-sensitivity, Radiofrequency, EHS, Idiopathic, Environmental, Intolerance fields, Mobile phone

Brief summary

The purpose of the study is to evaluate efficacy of a 14 months follow-up and individual medical care of electro-sensitive patients: by measurement of health status, sensitivity to electromagnetic fields exposures, and quality of life.

Detailed description

110 patients suffering from Idiopathic Environmental Intolerance attributed to electromagnetic fields (IEI-EMF) are expected in this trial. Type of trial: Interventional multicenter study, non-randomized, with measurement before and after intervention. Each patient is his own control. Primary outcome: Efficacy of an individual medical care on electro sensitive (IEI CEM) patients evaluated from the improvement of health status, sensitivity to electromagnetic fields (EMF) exposure, and quality of life. Scheme: Visit 1(T0): Patients undergo a specialized medical examination: a standardized medical record is filled in. Physicians evaluate the psychological impact of IEI-EMF and a psychotherapeutic care is proposed if necessary. Patients fill in 2 self-questionaries: quality of life (SF-36) and EMF exposure sensitivity. After the visit 1, a symptoms self-administrated questionary n°1 is completed during 7 days. 1 month after inclusions (T1), radiofrequencies (RF) are recorded by a dosimeter worn by patients for 7 days; patient fill-in the symptoms self-administrated questionary n° 2 during the same time. Visit 2: 6 months after inclusion, analysis of symptoms and RF exposure is restituted at patient. An adapted care is proposed. 12 months after inclusion (T12), patients complete the symptoms self-administrated questionary n°3. Visit 3: 14 months after inclusion (T14), patients have medical examination and complete the quality of life and EMF exposure sensitivity self-questionaries. Standardized medical record is filled in by physicians. Patient and physician discuss the global and comparative analysis of individual results. Inclusion duration: 24 month; Follow-up: 14 months; Study duration: 38 months.

Interventions

OTHERIndividual medical Care

Individual medical care in occupational and environmental diseases centers

OTHERIndividual electromagnetic exposures

During 7 days, patient hold a dosimeter measuring their electromagnetic exposures for FM, TV, GSM, DECT, WIFI, TETRA and relay antenna emissions. During this week, patients notify intensity and time of their symptoms on a self-questionary

Sponsors

ANSES, France
CollaboratorUNKNOWN
INERIS, Verneuil-En-Halatte, France
CollaboratorUNKNOWN
URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects who declare themselves to be intolerant to electromagnetic fields * Subjects over 18 years old * Subjects affiliated to a social security scheme * Subjects who signed the consent form

Exclusion criteria

* Subject with a disorder of the understanding of the French language at the discretion of the investigator * Pregnant women, * Persons deprived of their liberty, persons under guardianship, and persons in emergency situations.

Design outcomes

Primary

MeasureTime frameDescription
Measurement of symptoms severityAt 12 months after inclusion .At month 12 months the severity of symptoms is evaluated by a self-questionary filled in during 7 days. The level of severity of each symptom occurring during a week, will be self-evaluated by the patient on the base of a 0 to 5 scale. Following the intervention we expect a reduction in the severity of symptoms described.
Measurement of symptoms frequencyAt 12 months after inclusionAt month 12 months the symptoms frequency is evaluated by a self-questionary filled in during 7 days. Each symptom occurring during a week is reported by the patient allowing calculation of a frequency in symptoms appearance. Following the intervention we expect a reduction in the frequency of symptoms described.
Sensitivity to electromagnetic fieldsat 14 monthsAt visit 3 (14 months) the EMF sensitivity is evaluated by the self-questionary.

Secondary

MeasureTime frameDescription
Quality of life evaluationat 14 months.At visit 3 (14 months), the quality of life is evaluated by the self-questionary (SF-36)
Compliance to the study designAt each Visit (Day 0, Month 1, Month 6 and month 14)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026